Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Interpharm S.A. is a specialized Greek pharmaceutical company focused on the importation, marketing, and distribution of innovative therapeutic products. Established in 1989 and headquartered in Kifissia, the company has built a strong reputation as a strategic partner for international biopharmaceutical manufacturers seeking to enter the Greek market. Interpharm primarily focuses on critical therapeutic areas such as immunology, hematology, and intensive care, with a particular emphasis on blood-derived products and hospital-use medicines. The company represents prominent global firms including Biotest and Kedrion, ensuring the availability of specialized treatments like human immunoglobulins and coagulation factors. Operating a sophisticated logistics network compliant with international quality standards, Interpharm plays a vital role in the Greek healthcare supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Interpharm Pharmaceutical Products.